New NIH R56 grant on ETEC vaccination with dmLT Adjuvant. The objective of this proposal is to test samples from an ETEC vaccine clinical trial and seek to understand why some formulations resulted in better immune responses to the vaccine. The Norton lab will work with the Naval Military Research Center and Henry Jackson Foundation with their recent Phase 1 and Phase 2 clinical trial specimens.
